Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RISANKIZUMAB-RZAA: 65,422 Adverse Event Reports & Safety Profile

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra
65,422
Total FAERS Reports
2,269 (3.5%)
Deaths Reported
14,095
Hospitalizations
65,422
As Primary/Secondary Suspect
192
Life-Threatening
247
Disabilities
Prescription
Status

FDA Application: 761105 ·

First Report: 19890901 · Latest Report: 20250925

What Are the Most Common RISANKIZUMAB-RZAA Side Effects?

#1 Most Reported
Psoriasis
6,896 reports (10.5%)
#2 Most Reported
Drug ineffective
2,885 reports (4.4%)
#3 Most Reported
Pain
2,584 reports (3.9%)

All RISANKIZUMAB-RZAA Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Psoriasis 6,896 10.5% 12 778
Drug ineffective 2,885 4.4% 6 379
Pain 2,584 4.0% 18 571
Fatigue 2,483 3.8% 4 446
Arthralgia 2,419 3.7% 7 419
Pruritus 2,311 3.5% 2 213
Covid-19 2,145 3.3% 55 640
Death 1,700 2.6% 1,637 80
Fall 1,666 2.6% 32 782
Surgery 1,662 2.5% 5 245
Headache 1,554 2.4% 5 239
Diarrhoea 1,427 2.2% 7 475
Crohn's disease 1,338 2.1% 12 685
Device issue 1,245 1.9% 1 168
Rash 1,188 1.8% 2 148
Nasopharyngitis 1,158 1.8% 6 155
Nausea 1,104 1.7% 10 370
Therapeutic response shortened 1,089 1.7% 1 88
Pneumonia 1,079 1.7% 55 744
Erythema 1,051 1.6% 2 136

Who Reports RISANKIZUMAB-RZAA Side Effects? Age & Gender Data

Gender: 57.1% female, 42.9% male. Average age: 56.5 years. Most reports from: US. View detailed demographics →

Is RISANKIZUMAB-RZAA Getting Safer? Reports by Year

YearReportsDeathsHosp.
2000 1 0 0
2001 1 0 0
2002 1 0 0
2003 2 0 0
2004 3 0 0
2005 3 0 1
2006 2 0 1
2007 2 0 0
2008 6 0 6
2009 7 0 1
2010 6 0 1
2011 4 0 0
2012 10 0 0
2013 14 0 4
2014 18 0 4
2015 21 0 6
2016 19 0 5
2017 20 1 7
2018 56 0 10
2019 529 14 174
2020 1,721 92 676
2021 2,781 171 964
2022 9,160 185 1,174
2023 7,483 283 2,439
2024 9,058 333 3,009
2025 6,204 232 1,988

View full timeline →

What Is RISANKIZUMAB-RZAA Used For?

IndicationReports
Psoriasis 40,890
Crohn's disease 12,561
Product used for unknown indication 7,604
Psoriatic arthropathy 6,970
Colitis ulcerative 786
Rheumatoid arthritis 252
Illness 79
Hidradenitis 65
Maternal exposure timing unspecified 65
Guttate psoriasis 64

RISANKIZUMAB-RZAA vs Alternatives: Which Is Safer?

RISANKIZUMAB-RZAA vs RISDIPLAM RISANKIZUMAB-RZAA vs RISEDRONATE RISANKIZUMAB-RZAA vs RISEDRONIC ACID RISANKIZUMAB-RZAA vs RISPERDAL RISANKIZUMAB-RZAA vs RISPERDAL CONSTA RISANKIZUMAB-RZAA vs RISPERIDONE RISANKIZUMAB-RZAA vs RITALIN RISANKIZUMAB-RZAA vs RITLECITINIB RISANKIZUMAB-RZAA vs RITODRINE RISANKIZUMAB-RZAA vs RITONAVIR

Official FDA Label for RISANKIZUMAB-RZAA

Official prescribing information from the FDA-approved drug label.